Showing results (281-290 of 317) with videos related to

Sort By:
Pageof 32
Leukemia|May 29, 2015
Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98-HOXA9-induced myeloid diseaseA P Deveau, A M Forrester, A J Coombs, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 13, 2017
hace1 Influences zebrafish cardiac development via ROS-dependent mechanismsBabak Razaghi, Shelby L Steele, Sergey V Prykhozhij, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 6, 2024
tp53 R217H and R242H mutant zebrafish exhibit dysfunctional p53 hallmarks and recapitulate Li-Fraumeni syndrome phenotypesKim Kobar, Lissandra Tuzi, Jennifer A Fiene, et al.
JAMA Network Open|July 9, 2020
Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI RegistryDavid W Biery, Adam N Berman, Avinainder Singh, et al.
Journal of the American Heart Association|May 18, 2024
Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Science Translational Medicine|December 16, 2014
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenaseYan Liu, Aarti Asnani, Lin Zou, et al.
Cardiovascular Diabetology|July 18, 2024
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Clinical Cardiology|September 7, 2020
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) RegistryAdam N Berman, David W Biery, Curtis Ginder, et al.
JACC. Advances|July 19, 2025
Identifying High-Risk Obese Individuals Without Diabetes for GLP-1RA Therapy Using Coronary CTACamila V Blair, Daniel Huck, Stephanie A Besser, et al.
American Heart Journal|July 16, 2023
A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH)Adam N Berman, Curtis Ginder, Xianghong S Wang, et al.
Pageof 32